BofA Securities has reiterated its Buy rating and price target on ASML, stating that the recent selloff was an overreaction. The bank estimates that a shift by China to domestic DUV tools would only reduce ASML's next year's sales by approximately €1.4 billion (2.4%), emphasizing ASML's unmatched EUV leadership and viewing its current valuation as an attractive buying opportunity.